lansoprazole has been researched along with Hypocalcemia in 2 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
Hypocalcemia: Reduction of the blood calcium below normal. Manifestations include hyperactive deep tendon reflexes, Chvostek's sign, muscle and abdominal cramps, and carpopedal spasm. (Dorland, 27th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Krupa, LZ | 1 |
| Fellows, IW | 1 |
| Subbiah, V | 1 |
| Tayek, JA | 1 |
2 other studies available for lansoprazole and Hypocalcemia
| Article | Year |
|---|---|
Lansoprazole-induced hypomagnesaemia.
Topics: Aged; Female; Humans; Hypocalcemia; Lansoprazole; Magnesium; Magnesium Deficiency; Proton Pump Inhib | 2014 |
Tetany secondary to the use of a proton-pump inhibitor.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Female; Humans; Hypocalcemia; Lansoprazole; Middle Aged; Om | 2002 |